JCB logo
Epitomics: The Rabbit Monoclonal Company
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 3 January 2006. doi:10.1083/jcb.200506189
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 172, Number 1, 127-137
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1392K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhong, F.
Right arrow Articles by Distelhorst, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhong, F.
Right arrow Articles by Distelhorst, C. W.
Related Collections
Right arrowRelated Article
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Article

 Bcl-2 differentially regulates Ca2+ signals according to the strength of T cell receptor activation

Fei Zhong1, Michael C. Davis1,2, Karen S. McColl1, and Clark W. Distelhorst1,2,3,4

1 Department of Medicine, Case Western Reserve University
2 Department of Pharmacology, Case Western Reserve University
3 Comprehensive Cancer Center, Case Western Reserve University
4 University Hospitals of Cleveland, Cleveland, OH 44106

Correspondence to Clark W. Distelhorst: cwd{at}case.edu

To investigate the effect of Bcl-2 on Ca2+ signaling in T cells, we continuously monitored Ca2+ concentration in Bcl-2–positive and –negative clones of the WEHI7.2 T cell line after T cell receptor (TCR) activation by anti-CD3 antibody. In Bcl-2–negative cells, high concentrations of anti-CD3 antibody induced a transient Ca2+ elevation, triggering apoptosis. In contrast, low concentrations of anti-CD3 antibody induced Ca2+ oscillations, activating the nuclear factor of activated T cells (NFAT), a prosurvival transcription factor. Bcl-2 blocked the transient Ca2+ elevation induced by high anti-CD3, thereby inhibiting apoptosis, but did not inhibit Ca2+ oscillations and NFAT activation induced by low anti-CD3. Reduction in the level of all three inositol 1,4,5-trisphosphate (InsP3) receptor subtypes by small interfering RNA inhibited the Ca2+ elevation induced by high but not low anti-CD3, suggesting that Ca2+ responses to high and low anti-CD3 may have different requirements for the InsP3 receptor. Therefore, Bcl-2 selectively inhibits proapoptotic Ca2+ elevation induced by strong TCR activation without hindering prosurvival Ca2+ signals induced by weak TCR activation.

F. Zhong and M.C. Davis contributed equally to this paper.

Abbreviations used in this paper: InsP3, inositol 1,4,5-trisphosphate; NFAT, nuclear factor of activated T cells; siRNA, small interfering RNA; TCR, T cell receptor.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Selective calcium blockade
Nicole LeBrasseur
J. Cell Biol. 2006 172: 3. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents